Table 1.
Micelles | Mass ratio (mg: mg)a |
Size (nm)b | PDIC | DLC(%)d | DLE(%)e | Stabilityf |
---|---|---|---|---|---|---|
POEG-b-PSAHA: | 63.7 ± 0.7 | 0.14 ± 0.01 | ||||
POEG-b-PSAHA: | 5:1 | 78.4 ± 0.4 | 0.22 ± 0.01 | 14.9 | 89.3 | 5 d |
DOX | ||||||
POEG-b-PSAHA: | 10: 1 | 75.9 ± 0.6 | 0.18 ± 0.01 | 8.2 | 90.6 | 9 d |
DOX | ||||||
POEG-b-PSAHA: | 20:1 | 73.9 ± 0.9 | 0.26 ± 0.01 | 4.5 | 93.5 | 17 d |
DOX | ||||||
POEG-b-PSAHA: | 30: 1 | 79.7 ± 0.3 | 0.23 ± 0.01 | 92.3 | 32 d | |
DOX | 3.0 | |||||
POEG-b-PSAHA: | 50:1 | 86.6 ± 0.2 | 0.20± 0.01 | 1.9 | 96.7 | 50 d |
DOX |
DOX concentration in micelles was kept at 0.5 mg/mL.
Measured by dynamic light scattering particle sizer.
PDI = polydispersity index.
DLC = drug loading capacity.
DLE = drug loading efficiency.
Data mean there was no noticeable size change and visible precipitates during the follow-up period at 4 °C.